FDA approves Journavx (suzetrigine), a new opioid designed to reduce addiction and overdose risks.

WEDNESDAY, Jan. 29, 2025 -- For adults with opioid use disorder (OUD) receiving buprenorphine, a mindfulness-based group is similar to a recovery...

WASHINGTON (AP) — Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose...

WASHINGTON (AP) — Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose...

A new study suggests that older adults whose cholesterol levels change significantly over time may have a higher risk of developing dementia compared...

FRIDAY, Jan. 31, 2025 -- The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or...

FRIDAY, Jan. 31, 2025 -- The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or...

Engaging in regular physical activity before a cancer diagnosis can significantly reduce the risk of cancer progression and mortality, according to...

A good night’s sleep often sets the stage for a positive day. But for the nearly quarter of American adults struggling with mental illness, a good...

Disparities in how high blood pressure and cardiovascular risks may develop among South Asian and East Asian adults in the United Kingdom highlight...